Chirantan Chatterjee

Visiting Fellow
Biography: 

Chirantan Chatterjee is a visiting fellow at the Hoover Institution. Chatterjee was previously the Edward Teller National Fellow at the Hoover Institution.

Chatterjee is an economist with research interests in economics of innovation, applied microeconomics, pharmaceutical economics, and global health. He is currently an Associate Professor in Business Policy and Economics at the Indian Institute of Management, Ahmedabad where he also holds the ICICI Bank Chair in Strategic Management. He has been published in top peer- reviewed journals like the RAND Journal of Economics, the Journal of Health Economics, the Journal of Law & Economics, Research Policy, Production and Operations Management, the Journal of Business Ethics, Social Science & Medicine, Health Policy and Planning, Economic and Political Weekly, and the Journal of Antitrust Enforcement. He has also published for Brookings Press, Oxford University Press (India), and the National Bureau of Economic Research (NBER).

Chatterjee’s dissertation work on the economics of innovation and intellectual property (IP) in the global pharmaceutical industry was supported by the National Science Foundation (NSF), and in 2015 his research was cited on NSF’s Science of Science Policy website. In 2017, Chatterjee was invited to chair the round table on IP and Access to Medicines at the 2017 Annual Conference of European Policy for Intellectual Property in Bordeaux France.

Chatterjee has also consulted with the World Bank and the Competition Commission of India. His input has been cited in a 2015 Tarun Khanna Committee Report by the National Institution for Transforming India (NITI) Aayog, currently India's central planning authority, also formulating innovation and entrepreneurship policy for the Indian economy. At the Indian Institute of Management (IIM) Bangalore, where he was previously a faculty member between 2011–16, Chatterjee conceptualized and chaired the First India Conference on Innovation, Intellectual Property and Competition, a first of its kind international innovation policy conference in India. This conference convened again in 2018 with Chatterjee cochairing the event as a faculty member in economics and public policy at the Indian School of Business, where he also was the Bharti Institute and Max Institute Research Fellow in Public Policy and Healthcare.

Chatterjee's deep passion about Indian healthcare markets and for democratizing education has also resulted in the first ever MOOC on health care markets in India in 2016, available through edX. In his spare time, he regularly contributes op-eds on economics and public policy issues for national dailies like LiveMint, Economic Times, Times of India, Hindu Business Line, and the Hindustan Times and tweets @chiruchat. He earned a PhD and an MPhil in public policy and management from the Carnegie Mellon University in 2011. Prior to his doctoral education, Chatterjee worked as a business journalist for the Economic Times, India’s leading business daily after earning his BTech (civil engineering) from the Indian Institute of Technology, Roorkee and MBA from the Indian Institute of Management Calcutta.

Filter By:

Topic

Type

Recent Commentary

Analysis and Commentary

Data Security, Data Breaches, And Compliance

by Chirantan Chatterjee, D. Daniel Sokolvia SSRN
Sunday, November 17, 2019

This chapter explores the attributes of compliance in the context of data breaches. First, it identifies the sort of corporate governance problem that data breaches create. Then, it approaches the empirical work related to data breaches and to the organization of compliance-based responses in terms of risk assessment, training and compliance, both preemptively and after a breach.

Analysis and Commentary

The 2019 Nobel Prizes Send Out Mixed Messages

by Chirantan Chatterjeevia The Telegraph
Friday, October 25, 2019

The world is going through a morality conundrum. This year’s Nobel Prizes reflect this as well.

Bad Medicine: The Value Of Monitoring Banned Drugs

by Chirantan Chatterjee
Wednesday, August 28, 2019

These are tough times around the world when it comes to regulating flawed medicines that are banned from the marketplace. Last month, the Washington Post reported details from a DEA database of 76 billion opioid pills sold in the United States between 2006 and 2012, showing that some six companies distributed 75 percent of the pills during that period.

Featured

Budget 2019 Needs To Have A Holistic View On Where Education In India Needs To Go

by Chirantan Chatterjee, Eric Hanushekvia The Indian Express
Wednesday, July 3, 2019

With the new Indian government shortly coming up with its first full federal budget and with education sector outlays being actively discussed, it is time to take a broader, holistic view of where Indian education needs to go. Rabindranath Tagore, who was the first non-European and Indian to win the Nobel Prize in literature in 1913, once noted, “Don’t limit a child to your own learning, for he was born in another time”. 

Analysis and Commentary

What Do Shifting Trends In Medical Care Have To Do With Violence Against Doctors?

by Chirantan Chatterjeevia The Telegraph
Friday, June 21, 2019

The doctors’ strike — it has now been resolved — and the subsequent collapse of West Bengal’s healthcare infrastructure should remind us that contempt for doctors is nothing new.

Analysis and Commentary

The Devil Is In The Device, Not The Platform

by Chirantan Chatterjee mentioning George P. Shultz, Condoleezza Rice, Joseph Nye, Niall Fergusonvia The Hill
Monday, June 10, 2019

With the buzz around 2020 U.S. elections building, and an election in another large democracy, India, just concluded, it is time for societies to place more of an emphasis on mobile phone regulation than they do on social media.

Analysis and Commentary

What Makes The Poll Worker Tick

by Chirantan Chatterjeevia The Telegraph
Friday, May 17, 2019

Be it the defiling of a statue of Ishwarchandra Vidyasagar, slapping leaders during campaigning or influencing votes within polling booths, the unsung but assiduous work of the Indian poll worker may be the central story of the 2019 general elections.

Analysis and Commentary

Don’t Acquire A Company Until You Evaluate Its Data Security

by Chirantan Chatterjee, D. Daniel Sokolvia Harvard Business Review
Tuesday, April 16, 2019

When Marriott International acquired Starwood in 2016 for $13.6 billion, neither company was awareof a cyber-attack on Starwood’s reservation system that dated back to 2014. The breach, which exposed the sensitive personal data of nearly 500 million Starwood customers, is a perfect example of what we call a “data lemon” — a concept drawn from economist George Akerlof’s work on information asymmetries and the “lemons” problem.

Analysis and Commentary

Someone Lift The Online Fog

by Chirantan Chatterjeevia The Economic Times
Wednesday, February 20, 2019
On February 14, even as the news of the grisly terrorist attack in Pulwama, Jammu & Kashmir, rocked India, the Indo-US Commercial Dialogue and the Indo-US CEO Forum convened in New Delhi. GoI noted that the forum will help highlight key market access issues enabling ease of doing business in both countries. But was that mere lip service? Or, as recent reports suggest, could India and the US be heading for a trade war?
Analysis and Commentary

Pay For Your Facebook posts?

by Chirantan Chatterjee, Haifeng Huangvia Economic Times (India)
Wednesday, February 13, 2019

Would democracy worldwide be safer if social media companies like Facebook self-regulated and made people actually pay for their posts? This is a valid question at a time when Facebook has started labelling ‘political ads’ before India goes to polls, while last week, regulators in Germany outlawed the company’s ‘unrestricted collection and assigning of non-Facebook data’ (read: ads) to user accounts.

Pages